Neuroscience
Ischemia
100%
Middle Cerebral Artery
83%
Brain Ischemia
75%
Cognitive Disorders
60%
Neurodegeneration
57%
B Cell
45%
Osteopontin
45%
Microglia
42%
Myelin
33%
Neuroprotective Agent
29%
Receptor Agonists
28%
Necrosis
28%
Macrophage
27%
Magnetic Resonance Imaging
26%
Neurodegenerative Process
22%
Neurofilament
22%
Neuroprotection
22%
Diabetes Mellitus
22%
angiotensin[1-7]
22%
Fatty Acids
22%
Metabolic Pathway
22%
Foam Cell
22%
Tropomyosin
22%
Ketamine
22%
Thyronamine
22%
Thyroxine Derivative
22%
Interferon
22%
Anesthetics
22%
Reprogramming
22%
L-DOPA
22%
Cell Activation
22%
Kinase
22%
T Cell
22%
Dyskinesia
22%
TLR9
22%
Immunoglobulin A
22%
Brain Injury
22%
Transcription Factor Nrf2
22%
Transforming Growth Factor Beta
22%
Motor Cortex
18%
Parkinson's Disease
16%
Astrocyte
16%
Anterior Cerebral Artery
15%
Myeloid
15%
Neurogenesis
13%
Brain-Derived Neurotrophic Factor
12%
Axonal Degeneration
12%
Anti-Inflammatory
11%
Excitotoxicity
11%
Oxidative Stress
11%
Keyphrases
Mouse Model
52%
B Lymphocytes
45%
Permanent Focal Ischemia
45%
Dementia
41%
Transient Middle Cerebral Artery Occlusion (tMCAO)
30%
Stroke Lesion
26%
Intravenous Ketamine
22%
Bifidobacterium Animalis
22%
Lactis
22%
Vascular Cognitive Impairment
22%
Myelin Repair
22%
Mixed Dementia
22%
Post-stroke Dementia
22%
Delayed Administration
22%
Chronic Stage
22%
Low Variability
22%
Thyronamines
22%
Nasal Administration
22%
Autoimmunity
22%
2-hydroxypropyl-β-cyclodextrin
22%
C57BL
22%
Chronic Stroke
22%
Ferumoxytol
22%
Cognitive Impairment
22%
Related Dementia
22%
Diabetic Brain
22%
Pathophysiology
22%
High-throughput
22%
Pharmacological Preconditioning
22%
Segmented Filamentous Bacteria
22%
Character Comparisons
22%
LM11A-31
22%
Functional Deficits
22%
Stroke Model
17%
Horizontal Ladder
17%
Cortical Infarcts
15%
Behavioral Deficits
15%
Large Lesions
12%
Promising Target
11%
Stroke Recovery
11%
Neurodegenerative Processes
11%
Infarction
11%
Peri-infarct Depolarization
11%
Stroke Pathophysiology
11%
Neuroprotective Drugs
11%
Survivors
11%
Lymphocyte Activation
11%
Chemokine Responses
11%
Middle Cerebral Artery
10%
Hypoxia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
91%
Infarction
49%
Brain Ischemia
48%
Pathophysiology
45%
Cognitive Defect
29%
Mouse
29%
Bifidobacterium animalis
22%
Brain Injury
22%
angiotensin[1-7]
22%
Excitotoxicity
22%
3-Iodothyronamine
22%
Thyroxine Derivative
22%
Cyclodextrin
22%
Nasal Administration
22%
Disease
22%
Ferumoxytol
22%
Toll Like Receptor Agonist
22%
Receptor Agonist
22%
Experimental Stroke
22%
Neuroprotective Agent
11%
Heart Failure
11%
Nerve Degeneration
7%
Pharmacotherapy
5%
C57BL 6 Mouse
5%
